Refined Resin Technologies is a cannabinoid research and refinery company that provides B2B and B2C products and services to licensed dispensaries and distributors in the medical cannabis supply chain.
- Refined Resin has a facility in Oakland, California under a long-term lease, which it plans to retrofit a large, state-of-the-art medical cannabis extraction laboratory.
Refined Resin also plans to provide white-labeling services to licensed brands and infused product manufacturers who do not have direct access to compliant production facilities.
Refined Resin’s principles have extensive experience in extraction, manufacturing and business operations.
- Under the Royalty Agreement (fully funded), FinCanna will earn a perpetual royalty ranging from 14% to 5% of Refined Resin’s consolidated annual revenues, based on agreed upon financial benchmarks and subject to certain buy-back options.
The effective royalty rate to FinCanna is 11.75% on the first US$160 million of Refined Resin’s consolidated annual revenues.
To learn more about Refined Resin, visit: https://www.refinedresin.com/